首页|不同纤维蛋白原检测方法在患者溶栓过程中的应用研究

不同纤维蛋白原检测方法在患者溶栓过程中的应用研究

扫码查看
目的 探讨不同方法纤维蛋白原(fibrinogen,Fib)检测结果在患者药物溶栓过程中的应用.方法 选取我院在2021年9月至2023年12月收治的需药物溶栓患者78例为实验组,全部为应用尿激酶患者(急性心梗溶栓43例,肿瘤放疗科溶栓患者35例),所有患者药物溶栓术后均进行Clauss法、PT-衍算法、免疫比浊法检测Fib浓度,Fib以Clauss法检测结果为标准,覆盖0.4~5.05g/L区间.同时选取非溶栓组标本110例为对照组,Fib以Clauss法检测结果为标准,分为3个区间,<1.6g/L区间内为低水平组,30例;1.6~4.0g/L区间内为中水平组,40例;>4.0g/L区间内为高水平组,40例,进行Clauss法、PT-衍算法、免疫比浊法检测Fib浓度.通过对溶栓与非溶栓组3种方法学结果比较,分析在溶栓时不同检测方法对Fib浓度的影响.结果 非溶栓组标本中,Fib浓度在<1.6g/L和1.6~4.0g/L区间内,Clauss法与PT-衍算法、免疫比浊法比较,差异无统计学意义(P>0.05);Fib浓度在>4.0g/L区间内,PT-衍算法与免疫比浊法检测结果相比较,差异无统计学意义(P>0.05),两种方法均高于Clauss法,差异有统计学意义(P<0.05).在溶栓实验组中,PT-衍算法与免疫比浊法检测结果相比较,差异无统计学意义(P>0.05),均高于Clauss法结果,差异有统计学意义(P<0.05).结论 在溶栓过程中,PT-衍算法与免疫比浊法受溶栓片段的影响,结果明显高于检测Fib功能的Clauss法,建议在溶栓过程中使用Clauss法检测Fib浓度.
The Investigation of Diverse Fibrinogen Detection Techniques Inthe Thrombolytic Procedure
Objective To investigate the application of different methods for fibrinogen(fibrinogen,Fib)detection in patients undergoing therapeutic thrombolysis.Methods A total of 78 patients admitted to our hospital from September,2021 to December,2023 for therapeutic thrombolysis were selected as the experimental group.All patients received urokinase treatment(43 cases with acute myocardial infarction thrombolysis and 35 cases with tumor radiotherapy thrombolysis),and Fib concentrations were measured by Clauss method,PT-derivative method,and immunoassay method after thrombolysis.The standardization range of Fib by Clauss method was 0.4-5.05g/L.Simultaneously,110 non-thrombolytic specimens were selected as the control group,and Fib was standardized by Clauss method into three intervals:<1.6g/L interval represented the low level group with 30 cases;1.6-4.0g/L interval represented the medium level group with 40 cases;>4.0g/L interval represented the high level group with 40 cases.Fib concentrations were measured by Clauss method,PT-derivative method,and immunoassay method in both groups to analyze the impact of thrombolysis on Fib concentration.Results In non-thrombolytic specimens,there was no statistical difference in Fib concentrations within<1.6g/L and 1.6-4.0g/L intervals between Clauss method and PT-derivative/immunoassay methods(P>0.05).Within>4.0g/L range,there was no statistical difference(P>0.05)between results obtained from PT-derivative/immunoassay methods in detecting Fib concentration;However,both methods yielded higher values than those obtained from Clauss method with a statistically significant difference(P<0.05).In contrast,in the thrombolytic experimentgroup,no statistical difference(P>0.05)was observed between the results obtained from PT-derived method and immunoassay method in detecting Fib concentration;However,both methods yielded higher values than those obtained from Clauss method with a statistically significant difference(P<0.05).Conclusion During thrombolytic therapy,PT-derived method and immunoassay method are affected by the thrombolytic fragments,resulting in significantly higher Fib concentrations than Clauss method for detecting Fib function.Therefore,it is recommended to use Clauss method to detect Fib concentrations during thrombolytic therapy.

FibClauss methodPT-derivative methodImmunoassayThrombolysis

王波、孙群书、孟伟、孟庆书、马迎新、王聪

展开 >

阳光融和医院医学检验科,山东潍坊 261000

纤维蛋白原 Clauss法 PT-衍算法 免疫比浊法 溶栓

潍坊市卫生健康委员会科研项目计划

WFWSJK-2021-298

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(8)